Dementia and Geriatric Cognitive Disorders
Published by Karger
ISSN : 1420-8008 eISSN : 1421-9824
Abbreviation : Dement. Geriatr. Cogn. Disord.
Aims & Scope
As a unique forum devoted exclusively to the study of cognitive dysfunction, Dementia and Geriatric Cognitive Disorders concentrates on Alzheimer’s and Parkinson’s disease, Huntington’s chorea and other neurodegenerative diseases.
The journal draws from diverse related research disciplines such as psychogeriatrics, neuropsychology, clinical neurology, morphology, physiology, genetic molecular biology, pathology, biochemistry, immunology, pharmacology and pharmaceutics.
Strong emphasis is placed on the publication of research findings from animal studies which are complemented by clinical and therapeutic experience to give an overall appreciation of the field.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 1.9 |
| 2024 | 2.20 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.781 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q2 |
h-index
| Year | Value |
|---|---|
| 2024 | 127 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 7004 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 478 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Validation of the Addenbrooke's Cognitive Examination III in Frontotemporal Dementia and Alzheimer's Disease
Citation: 774
Authors: Sharpley, Samantha, Christopher, Eneida, John R.
-
Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy
Citation: 693
Authors: Javier, Barry, Linda, Isabel, Jordi, Teodoro, Bob, Cornelia, Stefanie, Claudia, Aimee, Sam, John, Miia, Henry, José Manuel, Helen, Linda, Mary, Martin, Howard H., Ruben
-
Subjective Memory Complaints and Cognitive Impairment in Older People
Citation: 498
Authors: Louise M., Alasdair M.J.
-
The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>
Citation: 467
Authors: A., M., J., S., H., H.-J., S.L., L.T.
-
Depression and Quality of Life in Older Persons: A Review
Citation: 456
Authors: Heidi, Guro Hanevold, Knut, Geir, Anne-Sofie
-
Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later
Citation: 423
Authors: Alina, Miia, Benjamin, Jufen, Rachel A.
-
Mental, Physical and Social Components in Leisure Activities Equally Contribute to Decrease Dementia Risk
Citation: 403
Authors: Anita, Stephanie, Hui-Xin, Merril, Bengt, Laura
-
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Citation: 390
Authors: Maria, Agneta, Kaarina, Lars, Ted, Björn, Lars, Åke, Masahiro, Elvar, Matti, Bengt, Lars-Olof
-
Interrater Reliability of the Modified Jadad Quality Scale for Systematic Reviews of Alzheimer’s Disease Drug Trials
Citation: 343
Authors: Mark, Christina, Anne, Louise, Franco, Yola
-
The Bayer Activities of Daily Living Scale (B-ADL)
Citation: 342
Authors: Ian, Hartmut, Perry, Hellmut